{"id":"W2511824391","doi":"10.18553/jmcp.2016.22.9.1064","title":"Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States","year":2016,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVRAZ (Canada)","funders":"Amgen","keywords":"Ivabradine; Medicine; Heart failure; Medicare Advantage; Formulary; Emergency medicine; Internal medicine; Cardiology; Heart rate; Health care; Pharmacology; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003283066,0.0007506397,0.0005483885,0.0006513685,0.0003876538,0.001253792,0.0006782516,0.0007540043,0.003585825],"category_scores_gemma":[0.009477921,0.0004353728,0.001466748,0.0008992091,0.0003955088,0.001101892,0.001115869,0.0009401346,0.0001738013],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008411148,"about_ca_system_score_gemma":0.004812787,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0758497,"about_ca_topic_score_gemma":0.05144781,"domain_scores_codex":[0.9972939,0.001838007,0.0001026288,0.0001511872,0.0002156125,0.0003987041],"domain_scores_gemma":[0.9973544,0.001379863,0.0005671108,0.00009143844,0.0003057415,0.0003014562],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.003218033,0.0009401994,0.181559,0.0003280834,0.001445187,0.0004575751,0.0001492039,0.7672189,0.000569692,0.005901927,0.00571503,0.03249723],"study_design_scores_gemma":[0.002488101,0.004864458,0.2243147,0.0006443819,0.002235153,0.0005300738,0.001461019,0.7430423,0.001197343,0.007649878,0.01144163,0.0001310053],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9794979,0.001216424,0.002445729,0.002396666,0.0000624469,0.0002522153,0.004227431,0.00004293448,0.009858295],"genre_scores_gemma":[0.9973194,0.0002668997,0.0008558788,0.000286075,0.000009113693,0.00008321708,0.0007903482,0.000004111649,0.0003849045],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0758497,"threshold_uncertainty_score":0.1508164,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009468308968254735,"score_gpt":0.3081205340478019,"score_spread":0.2986522250795472,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}